SXI Life Sciences
7 459,18
|
31,80
|
0,43 %
|
Analysen zu SXI Life Sciences-Werten
11.10.23 | Novartis Buy | Jefferies & Company Inc. | |
09.10.23 | Roche Equal-weight | Morgan Stanley | |
09.10.23 | Roche Underweight | JP Morgan Chase & Co. | |
05.10.23 | Novartis Neutral | JP Morgan Chase & Co. | |
05.10.23 | Novartis Buy | Deutsche Bank AG | |
05.10.23 | Sandoz Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.10.23 | Sandoz Overweight | Morgan Stanley | |
05.10.23 | Sandoz Overweight | JP Morgan Chase & Co. | |
04.10.23 | Novartis Neutral | UBS AG | |
04.10.23 | Novartis Buy | Deutsche Bank AG | |
03.10.23 | Novartis Buy | Deutsche Bank AG | |
29.09.23 | Roche Underweight | JP Morgan Chase & Co. | |
26.09.23 | Novartis Buy | Deutsche Bank AG | |
25.09.23 | Novartis Equal-weight | Morgan Stanley | |
22.09.23 | Novartis Buy | Deutsche Bank AG | |
12.09.23 | Roche Equal Weight | Barclays Capital | |
12.09.23 | Roche Sell | Deutsche Bank AG | |
12.09.23 | Roche Underweight | JP Morgan Chase & Co. | |
08.09.23 | Novartis Buy | Deutsche Bank AG |